Hussman Strategic Advisors, Inc. Crispr Therapeutics Ag Transaction History

Hussman Strategic Advisors, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	SELL	$43.47 - $67.77 $317,331 - $494,721	-7,300 Reduced 43.98%	9,300 $522,000
Q4 2022 Feb 08, 2023	BUY	$39.19 - $65.67 $242,978 - $407,154	6,200 Added 59.62%	16,600 $674,000
Q3 2022 Nov 02, 2022	SELL	$61.1 - $83.78 $635,440 - $871,312	-10,400 Reduced 50.0%	10,400 $680,000
Q2 2022 Sep 12, 2022	BUY	$43.23 - $73.83 $449,591 - $767,832	10,400 Added 100.0%	20,800 $1.26 Million
Q4 2021 Jan 31, 2022	SELL	$70.09 - $111.29 $140,180 - $222,580	-2,000 Reduced 16.13%	10,400 $788,000
Q3 2021 Nov 01, 2021	BUY	$110.2 - $156.64 $341,620 - $485,583	3,100 Added 33.33%	12,400 $1.39 Million
Q2 2021 Aug 03, 2021	BUY	$100.84 - $161.89 $574,788 - $922,772	5,700 Added 158.33%	9,300 $1.51 Million
Q1 2021 May 03, 2021	SELL	$110.72 - $210.04 $730,752 - $1.39 Million	-6,600 Reduced 64.71%	3,600 $439,000
Q4 2020 Feb 01, 2021	SELL	$79.67 - $173.23 $1.63 Million - $3.53 Million	-20,400 Reduced 66.67%	10,200 $1.56 Million
Q3 2020 Nov 02, 2020	BUY	$78.5 - $100.64 $1.2 Million - $1.53 Million	15,250 Added 99.35%	30,600 $2.56 Million
Q1 2020 May 01, 2020	BUY	$33.68 - $62.53 $171,768 - $318,903	5,100 Added 49.76%	15,350 $651,000
Q4 2019 Jan 31, 2020	BUY	$36.68 - $73.13 $375,970 - $749,582	10,250 New	10,250 $624,000

491

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.61B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.